(Q39907340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Anna Orlova

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Fredrik Y Frejd

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Eskender Mume

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stefan Sjöberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

10 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

692-701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-008-1003-y

18 January 2020

exact match

0 references

cites work

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-1003-Y

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-1003-Y

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging

21 January 2018

1 reference

12 December 2020

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

12 December 2020

Targeted therapy of cancer with radiolabeled antibodies

1 reference

12 December 2020

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

12 December 2020

Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting

1 reference

12 December 2020

[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography

1 reference

12 December 2020

Evaluation of ((4-hydroxyphenyl)ethyl)maleimide for site-specific radiobromination of anti-HER2 affibody.

1 reference

12 December 2020

Trastuzumab: triumphs and tribulations

1 reference

12 December 2020

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy

1 reference

12 December 2020

Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer

1 reference

12 December 2020

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules

1 reference

12 December 2020

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors

1 reference

12 December 2020

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

12 December 2020

Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.

1 reference

12 December 2020

Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors

1 reference

12 December 2020

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

1 reference

12 December 2020

Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity

1 reference

12 December 2020

Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent

1 reference

12 December 2020

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

1 reference

12 December 2020

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

12 December 2020

Radiolabeled antibody targeting of the HER-2/neu oncoprotein

1 reference

12 December 2020

Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules

1 reference

12 December 2020

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

1 reference

12 December 2020

Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules

1 reference

12 December 2020

Advancing role of radiolabeled antibodies in the therapy of cancer

1 reference

12 December 2020

Scaffolds for engineering novel binding sites in proteins

1 reference

12 December 2020

[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts

1 reference

12 December 2020

Tailoring antibodies for radionuclide delivery

1 reference

12 December 2020

99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma

1 reference

12 December 2020

In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules

1 reference

12 December 2020

Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

1 reference

12 December 2020

Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy

1 reference

12 December 2020

Astatinated trastuzumab, a putative agent for radionuclide immunotherapy of ErbB2-expressing tumours

1 reference

12 December 2020

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

1 reference

12 December 2020

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.

1 reference

12 December 2020

Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods

1 reference

12 December 2020

Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold

1 reference

12 December 2020

Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.

1 reference

12 December 2020

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

1 reference

12 December 2020

Slow internalization of anti-HER2 synthetic affibody monomer 111In-DOTA-ZHER2:342-pep2: implications for development of labeled tracers.

1 reference

12 December 2020

A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice

1 reference

12 December 2020

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules

1 reference

12 December 2020

Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.

1 reference

12 December 2020

Update: affibody molecules for molecular imaging and therapy for cancer.

1 reference

12 December 2020

10.1007/S00259-008-1003-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19066886%20AND%20SRC:MED&resulttype=core&format=json

release_oqnnzy255jhphbptgv2g2bi3h4

18 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqnnzy255jhphbptgv2g2bi3h4

24 November 2022

mapped directly with Wikidata item

1 reference